UroSens' Unattributed VC Round

UroSens raised a round of funding on June 19, 2013.

UroSens is developing diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. The Company has a worldwide exclusive license, from Cancer Research Technology, for …

Articles about UroSens' Unattributed VC Round: